News & Events
October 26, 2023 - October 27, 2023
C-Path to host its Scientific Breakthrough Summit 2023The summit featured presentations and panel discussions with C-Path collaborators from industry, academia, global regulatory agencies, nurses, parents and patients. The workshop: Explored the unmet needs and potential solutions relevant to specific aspects of type-1 diabetes, alpha-1 antitrypsin deficiency, lysosomal diseases, and neonatal indications. Demonstrated the critical role data sharing plays in enhancing drug development......
October 5, 2023
View Now — European Association of the Study of Diabetes Annual Meeting, C-Path T1D Consortium Presentation and ReceptionMembers of the C-Path team joined EASD 2023 for groundbreaking discussions on Immunotherapy and Beta Cell Preservation in Type 1 Diabetes, taking us from clinical trials to clinical practice. Click here to view the recordings....
August 30, 2023
NIDDK Central Repository 20th Anniversary Workshop: Promoting Secondary Research to Accelerate Medical Breakthroughs and InnovationThe National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) workshop highlights secondary use research that utilized resources generated from NIDDK-funded clinical research projects. The event also offers a review of NIDDK’s Data Ecosystem past, present, and future and launches a data challenge platform as part of the program’s vision for the future. C-Path’s T1D......
May 24, 2023
Improving the Design of Clinical Trials in T1D: Analysis of Data from the Trial Outcome Markers Initiative (TOMI) CollaborationWith presentations from JDRF, TrialNet and the TOMI-T1D Collaboration The Trial Outcome Marker Initiative brings together data from many contributors in the field comprising more than 10,000 individuals with new onset T1D including 2900 from 21 different clinical trials. Analysis of C-peptide, HbA1c and as well as composite outcomes will be discussed which has provided......
June 15, 2021 - June 16, 2021
VIEW NOW | Design of Clinical Trials in New-Onset Type 1 Diabetes: Regulatory Considerations for Drug DevelopmentCritical Path Institute held a free virtual workshop, Design of Clinical Trials in New-Onset Type 1 Diabetes: Regulatory Considerations for Drug Development, June 15-16, 2021. Workshop Summary The purpose of this scientific workshop was to discuss the existing evidence regarding the role of C-peptide in clinical trials intended to support regulatory decision making, unique regulatory considerations......